Hamps Bio Limited (HAMPS) — shareholding pattern, promoter holding, financials and share price
About Hamps Bio Limited (HAMPS)
Hamps Bio Limited operates in the Other Agricultural Products industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as HAMPS and on the BSE under scrip code 544312. Its ISIN is INE0QBD01018.
Incorporated in 2007, Hamps Bio Ltd is in the business of Pharmaceutical Formulation and Freeze-Drying Ingredient Manufacturing and Distribution [1]
Hamps Bio Limited is a company focused on ethical marketing and distribution of pharmaceutical and FMCG products, including pharma formulations and freeze-dried food items.
The company was originally incorporated as a private entity in 2007 and transitioned to a public limited company in 2023, planning an IPO to expand its equity base.
Listed peers in Other Agricultural Products: TGIF Agribusiness Ltd, Sunil Agro Foods Ltd, Pearl Green Clubs and Resorts Ltd, Vikas Wsp Ltd, Hindustan Agrigenetics Ltd, Khandelwal Extractions Ltd.
Valuation & Returns
10 Jul 2026At ₹25.52 a share on 10 Jul 2026, Hamps Bio Limited (HAMPS) was valued at a price-to-book of 2.74x on a book value of ₹9.3 per share. Solomo computes return on equity of -91.19% and return on capital employed of -29.9% from filed results.
- Industry P/E
- 33.81x
- P/B
- 2.74x
- Book value / share
- ₹9.3
- ROE
- -91.19%
- ROCE
- -29.9%
- ROA
- -46.42%
- Debt / equity
- 0.85x
- Dividend yield
- 0%
- EBITDA margin
- 4.32%
- 52-week range
- ₹13.36 – ₹35
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Hamps Bio Limited (HAMPS) reported revenue of ₹84.75 crore, net profit of ₹-7.39 crore and earnings per share of ₹-8.48. That compares with revenue of ₹66.69 crore and net profit of ₹2.98 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹44.83 crore and net profit ₹-5.43 crore (consolidated).
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue (₹ cr) | 66.69 | 84.75 |
| Net profit (₹ cr) | 2.98 | -7.39 |
| EPS (₹) | 3.43 | -8.48 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 7.69% | 2.93% |
| Profit growth | 34.81% | -40.00% |
| Stock price CAGR | - | 38% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 71.99% of Hamps Bio Limited (HAMPS). Market capitalisation was ₹22 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2025.
Largest disclosed public shareholders in Mar 2026: NARAYANAN OTTAPPATH 2.3%, ANIL GURMUKH BHAGWANI 1.56%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 71.99% | - | - | - | 28.01% |
| Sep 2025 | 71.99% | - | - | - | 28.01% |
| Mar 2025 | 71.99% | - | - | - | 28.01% |